SELECTIVE TARGETING OF MDMX TO TREAT BREAST CANCER
Grant number: 1123057 | Funding period: 2017 - 2019
Breast cancer (BrCa) is a leading cause of cancer death in women worldwide. BrCas unable to respond to current therapies have the worst outcomes. We propose a novel strategy to treat these cancers, based on our new findings. Our two protein targets are: (1) MDMX, that we found drives BrCa with its partner, (2) mutant p53, which causes cancer spread. We plan to directly target these drivers of aggressive BrCas, using new drugs that individually show great promise in trials in a number of cance
Related publications (6)
Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network
Sue Haupt, Franco Caramia, Alan Herschtal, Thierry Soussi, Guillermina Lozano, Hu Chen, Han Liang, Terence P Speed, Ygal Haupt
The disproportionately high prevalence of male cancer is poorly understood. We tested for sex-disparity in the functional integrit..
E6AP goes viral: the role of E6AP in viral- and non-viral-related cancers
Ivona Bandilovska, Simon P Keam, Cristina Gamell, Claudia Machicado, Sue Haupt, Ygal Haupt
Since its discovery, the E3 ubiquitin ligase E6-associated protein (E6AP) has been studied extensively in two pathological context..